Tag: cancer
Gold-based drug outperforms platinum in cancer treatment, new study finds
Gold-based chemotherapy drugs may soon be a stronger alternative to platinum-based treatments, according to new research from RMIT University.
UOW researchers explore safer cancer treatments with wearable x-ray sensors
A groundbreaking study led by the University of Wollongong (UOW) suggests that wearable organic x-ray sensors could revolutionise cancer treatment by improving the safety and precision of radiotherapy.
Centenary Institute secures funding for cutting-edge cancer research
The Centenary Institute has received funding from the RT Hall Trust to propel two pioneering cancer research projects.
Personalised cancer vaccines to be manufactured at New UQ lab
The University of Queensland (UQ) is set to revolutionise cancer treatment with the establishment of a new facility dedicated to producing personalised cancer vaccines, the university said in a media release.
UQ boosts biomanufacturing industry with new cancer treatment hub
A newly launched research and manufacturing hub at The University of Queensland is spearheading the manufacturing of precise cancer drugs.
La Trobe University to house BioNTech’s new mRNA manufacturing facility
La Trobe University’s Melbourne campus will soon become home to a new BioNTech facility that will manufacture new investigational mRNA therapies for serious diseases like cancer.
3D-printed tumour model paves way for faster, affordable, and less invasive cancer care
An international research team from the University of Waterloo has developed an innovative method that combines advanced bioprinting technologies with synthetic structures, such as microfluidic chips, to enhance 3D modelling of complex cancers.
Researchers identify new drug target to combat cancer drug resistance
Researchers at the University of Queensland (UQ) have identified a novel drug target that could potentially overcome drug resistance in cancer patients, thereby preventing tumour regrowth.
Immutep gets green light for large-scale cancer product manufacturing for clinical trials
Immutep Limited, a clinical-stage biotechnology company specialising in LAG-3 immunotherapies for cancer and autoimmune diseases, has received regulatory authorisation for the commercial manufacturing of Eftilagimod Alpha (efti) at a scale of 2,000 litres for clinical trial use.
Peter MacCallum Cancer Centre granted $1 million for mRNA research
Researchers at Peter MacCallum Cancer Centre are set to receive a $1 million grant from the Victorian government for the development of new mRNA treatments for various hard-to-treat cancers.